Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT04852822 · TERMINATED
Trial details
- NCT number
- NCT04852822
- Sponsor
- University of Washington
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-18
- Primary completion
- 2023-01-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.